CVS Health Corporation
CVS
$76.19
$2.012.71%
NYSE
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 174.04% | -489.32% | -42.61% | 8.21% | 1,789.66% |
| Total Depreciation and Amortization | 1.15% | -3.16% | 1.47% | 0.61% | -1.21% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -93.84% | 37,100.00% | -92.86% | 136.50% | -239.12% |
| Change in Net Operating Assets | 35.01% | -408.41% | -121.65% | 462.18% | 83.44% |
| Cash from Operations | 325.88% | -58.04% | -58.36% | 144.95% | 349.66% |
| Capital Expenditure | -12.32% | -14.99% | 18.30% | 3.26% | -14.63% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | 97.59% | -143.70% | -495.00% | -100.00% | 16.67% |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -9.83% | -268.79% | -29,900.00% | -99.57% | 108.67% |
| Cash from Investing | 4.26% | -103.81% | -34.38% | -39.31% | 83.66% |
| Total Debt Issued | -100.00% | 230.94% | -- | -- | 612.17% |
| Total Debt Repaid | 65.93% | -542.74% | 152.43% | 47.77% | -108.78% |
| Issuance of Common Stock | -26.50% | 148.94% | -67.36% | 657.89% | -83.33% |
| Repurchase of Common Stock | 35.00% | 82.46% | -936.36% | -175.00% | 0.00% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | 0.12% | 2.31% | -3.10% | -0.24% | -0.12% |
| Other Financing Activities | -81.58% | 272.73% | 4.35% | -147.92% | 500.00% |
| Cash from Financing | -47.03% | -271.46% | 134.56% | -641.07% | 127.14% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 76.06% | -259.20% | 14.84% | -16.17% | 130.70% |